Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. - Wikidata - awgldk - TriplyDB

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

http://www.wikidata.org/entity/Q48374829

about

Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy Risk factors for oligodendroglial tumors: a pooled international study Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors Age-related differences in 1p and 19q deletions in oligodendrogliomas Clinical management of grade III oligodendroglioma Molecular biology of gliomas: present and future challenges Recent advancements in multimodality treatment of gliomas Modern brain tumor imaging Oligodendroglioma: pathology, molecular mechanisms and markers IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.Epidemiologic and molecular prognostic review of glioblastoma Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors Survival and low-grade glioma: the emergence of genetic information Neuro-oncology: Five new things.International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors Survey of treatment recommendations for anaplastic oligodendroglioma Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.Magnetic resonance perfusion imaging in neuro-oncology.Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors.Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Molecular genetic analysis of archival gliomas using diagnostic smears.Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.

P2860

Q21261321-03C122C9-4B28-4CA3-B4C0-74E505F79D02 Q22242025-EB1184AE-00E8-4D30-AD63-129CFD99CC3A Q23910577-4EE51996-4D4A-4D9C-AB54-2994BD9D9E1C Q24194645-4FD32D1E-B481-4D07-B073-F22EB0606097 Q24242968-24BFFC07-4C54-4EB3-BC83-23E94F2CAF6C Q24555202-5113CAA6-054E-4F9A-8B5D-FE05FA67897B Q24618080-985BBD70-1269-4C40-83D3-EEBCAFDEE750 Q24671002-33BC5345-5654-453E-8781-142C71BA030B Q24685905-DB3844FA-0AF3-438A-9185-6C9A37AE9250 Q24805918-3C4D8817-BEA3-4370-804E-869269B0269D Q26801254-23396E4F-B09A-4FBA-B0D6-AD13F2ED45BD Q27001295-72E59275-1BC8-4EA0-90AD-D4338048E2CA Q27001724-649FE49E-DD6B-45C8-971E-1CC305A0EA50 Q27002344-658AEAEF-8019-41DB-A326-929F391973A8 Q27002448-35EA1F70-FC3B-474E-89EC-3DE7978C0EF7 Q28300822-8970AF14-BF57-4BA5-AE47-FEF9DA74D7E0 Q28383205-C42A11A0-404C-4E16-A156-7C081688A4CF Q28388251-0277DCB1-2F87-438D-A5C6-B7C9C33CF059 Q28395302-44CD7158-FAB7-42C4-9B32-76B137559F08 Q28716240-C99C6353-834A-48C5-A1C3-6FB415CF5422 Q29976922-5A7042C7-20B2-4B82-9032-0C3D29CB384F Q30090233-62A50DB2-EE17-4D1C-8577-3B5A828A49E0 Q30370204-A3258E95-201B-4CF4-A05E-817D0FE29F51 Q30395017-6D821997-77F2-4D3C-A007-D99028372B51 Q30415098-165B2765-E81A-43AB-AF78-BC701C593F6D Q30426724-B9AA6C09-A152-43FD-A4AF-E47B379B61F5 Q30441461-2EAF5597-A9E1-471E-BD61-E4C00ABDA777 Q30444816-BB89291B-CE74-4197-A0E0-0E9B79686A39 Q30448863-AE5AD7C3-B2A7-45B3-8D78-1FA34950050A Q30450445-D3AC79F7-FAB4-43C8-A387-B5E35C9F7E69 Q30479156-F9B6DEDC-1733-4CAE-B452-36636997DA5E Q30481789-483C06E2-A6D2-4DDC-8EFA-9EC25115D8C9 Q30542081-723B1D45-2476-4FA5-B4AD-02A90937EAA8 Q30581024-FB3B49CA-529D-4B25-AB30-A01D1B531200 Q30585474-5A07495E-805F-4868-B344-86314FD00BC9 Q30730673-8F7DA644-9251-4137-87E4-5ADD4000C8B2 Q30775012-29D478C1-0712-4B91-AFF3-E7C430E366D1 Q30872679-F350094F-01E1-4BD2-9118-7D30909D659F Q30952022-DAC2FD48-9810-4F2D-8EED-FB800D485208 Q30984368-921F3206-6422-4386-BED1-A90A4BD2BCA7

P2860

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

http://www.wikidata.org/entity/Q48374829

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@en

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@nl

type

label

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@en

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@nl

prefLabel

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@en

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@nl

P1433

Q48374829-8300ACF9-6888-4904-8191-5BF7B8DF1069

P1476

Q48374829-09D14B57-0388-463B-BDA4-D2FF9BCDDD96

P2093

Q48374829-225A339C-EFD2-43A7-A71C-C2962E84AFD1

Q48374829-293864CB-28C4-4380-A18D-EBB4BE6FE8DF

Q48374829-6113B6E4-06BF-4F2C-B2CC-31C0B239A522

Q48374829-68289AE4-E9B5-42B4-B126-B1D6F17E58A8

Q48374829-72DCAB43-7E67-4DFE-8204-F19D2D1FB6F1

Q48374829-7C701A0D-15CB-4A29-86B0-C3E063CBAD96

Q48374829-8BF146CA-4039-4384-BC95-4FCCEE377E35

Q48374829-9D4D1D51-2C00-49EB-9805-D04DFEE7ECE5

Q48374829-A5207554-8DA5-4A21-9002-B4BC1AE0C215

Q48374829-B62B2C52-6D40-4EB1-B375-A339BD575682

P304

Q48374829-65301E3C-6537-41C0-8C59-9A4249773B43

P31

Q48374829-083F55B3-409C-42BA-A65F-F9459369A59B

P356

Q48374829-AE7418C1-3532-4B6F-A24C-461E11D2D89A

P407

Q48374829-0DD26E6E-02E6-45A0-8406-2E7B82CBE991

P433

Q48374829-D4607CB5-1B60-432A-9530-EF3BCB89EB4A

P478

Q48374829-5CABC362-4E31-4337-A853-FA956746BC80

P577

Q48374829-4EA1B1C4-6898-42FB-A28D-4487DD1AA0A3

P5875

Q48374829-7DB8353F-5A22-4DAB-894A-3351CA2B79FC

P698

Q48374829-AC300EDA-8270-48FB-B258-42D5D802490F

P921

Q48374829-09860E78-F11B-4128-8F81-ED40A84E16C6

Q48374829-68F871EE-EABF-4226-9C88-730DB1C1E52F

Q48374829-C2D90C79-7ECD-4670-97A7-BFB83CF15C45

P356

P1433

Journal of the National Cancer Institute

P1476

Specific genetic predictors of ...... anaplastic oligodendrogliomas.

@en

P2093

D A Ramsay

http://www.w3.org/2001/XMLSchema#string

D K Lisle

http://www.w3.org/2001/XMLSchema#string

D M Finkelstein

http://www.w3.org/2001/XMLSchema#string

D N Louis

http://www.w3.org/2001/XMLSchema#string

D R Macdonald

http://www.w3.org/2001/XMLSchema#string

J G Cairncross

http://www.w3.org/2001/XMLSchema#string

J S Silver

http://www.w3.org/2001/XMLSchema#string

K Ueki

http://www.w3.org/2001/XMLSchema#string

M C Zlatescu

http://www.w3.org/2001/XMLSchema#string

P C Stark

http://www.w3.org/2001/XMLSchema#string

P304

1473-1479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/90.19.1473

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

1998-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13510619

http://www.w3.org/2001/XMLSchema#string

P698

9776413

http://www.w3.org/2001/XMLSchema#string

P921

oligodendroglioma